The Kansas Bioscience Authority has awarded more than $2 million to Kansas companies working to commercialize innovative bioscience technologies that will improve human and animal health.
The KBA board of directors approved the following investments May 9:
* Kansas City, KS.-based Aptakon, Inc. has been awarded $123,678 to partially match two federal awards to support additional development, scale up and support activities to commercialize proteomic biomarkers. This technology will make affinity reagents for detection of cancer and transcription factors faster and more inexpensively than currently available technologies, such as polyclonal and monoclonal antibodies.
To read the full, original article click on this link: Kansas Bioscience investments total $2 million - Johnson County Sun News Story - Kansas City
